Temporal trend of meningitis incidence rate in Roraima, Brazil (2016–2025)
TL;DR
A progressive increase in incidence was observed, associated with high lethality and a divergent pattern from the national trend, related to the post-COVID-19 pandemic resurgence, increased pathogen circulation, variations in vaccine coverage, or improvements in surveillance and notification.
Abstract
Background: Meningitis is a compulsory notification disease with high morbidity, mortality, and epidemic potential. In Northern Brazil, specifically in the state of Roraima, socioeconomic vulnerabilities, geographical barriers, and intense migratory flow may alter transmission dynamics and access to diagnosis. Temporal trend analysis allows for the identification of epidemiological shifts and guides surveillance and healthcare strategies. Objective: To analyze the temporal trend of the meningitis incidence rate in the state of Roraima, Brazil, between 2016 and 2025. Methods: This is a descriptive-analytical, quantitative time-series study using data on confirmed cases from the Notifiable Diseases Information System (Sinan) of the General Coordination of Health Surveillance. The incidence rate was calculated per 100,000 inhabitants based on official population estimates. The temporal trend was evaluated through simple linear regression (p<0,05), and the annual case-fatality rate was also calculated. Since it utilized public domain secondary data, the study was not submitted to a Research Ethics Committee. Results: A total of 279 cases of meningitis were confirmed during the period. The annual incidence was 3.80/100,000 inhabitants in 2016; 4.21 in 2017; 1.39 in 2018; 3.63 in 2019; 3.01 in 2020; 3.83 in 2021; 5.52 in 2022; 6.43 in 2023; 6.19 in 2024; and 5.38 in 2025, ranging from 1.39 to 6.43 cases/100,000 inhabitants. A significant increasing trend was observed (β=0,36; p=0,02), rising from a minimum level in 2018 (1.39/100,000) to a peak in 2023 (6.43/100,000), corresponding to a relative increase of 41.6% during the period. The annual average of cases rose from 18.4 in the 2016–2020 quinquennium to 37.4 in 2021–2025, with the highest growth between 2021 and 2023. This epidemiological behavior diverged from the national scenario, which showed a 63.3% reduction between 2019 (7.91/100,000) and 2025 (2.90/100,000). The cumulative case-fatality rate was 15.0%, with the highest values in 2020 (26.3%), 2019 (22.7%), and 2022 (16.2%). Conclusion: A progressive increase in incidence was observed, associated with high lethality and a divergent pattern from the national trend. This behavior may be related to the post-COVID-19 pandemic resurgence, increased pathogen circulation, variations in vaccine coverage, or improvements in surveillance and notification. The high lethality reinforces the severity of the disease and the need for early diagnosis, continuous surveillance, and control measures, including strengthening active surveillance, expanding etiological diagnosis, and qualifying care to reduce avoidable deaths.